Endocrine disorders in children with Prader-Willi syndromedata from 142 children of the French database
Tirzepatide is a dual GLP-1 and GIP receptor agonist that helps regulate appetite and blood sugar simultaneously
If symptoms are limiting at a current dose, clinicians will often hold the dose steady or slow the schedule rather than push forward
Semaglutide, used for type 2 diabetes management and weight loss, interacts with caffeine, a stimulant found in coffee, tea, soda, and energy drinks
This therapy is often considered when: Appetite regulation remains challenging Metabolic health requires medical input Injectable treatment is clinically appropriate Ongoing provider supervision is preferred Men receiving care at our Lake Mary clinic are assessed individually to ensure Tirzepatide fits within an overall care plan
If you have just started taking these medications or plan to take them it can be helpful to connect with a therapist to offer additional support in your health journey
